Epidemiology of two large measles virus outbreaks in Catalonia: What a difference the month of administration of the first dose of vaccine makes

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 3, 2013, Pages 675-680

  Torner, Nuria ^a,b,c   Anton, Andres ^d   Barrabeig, Irene ^a   Lafuente, Sara ^a   Parron, Ignasi ^a   Arias, Cesar ^a   Camps, Neus ^a   Costa, Josep ^d,e   Martinez, Ana ^a   Torra, Roser ^a   Godoy, Pere ^a   Minguell, Sofia ^a   Ferrus, Gloria ^a   Cabezas, Carmen ^a   Dóminguez, Angela ^b,c  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Elimination; Genotype; Measles; Outbreak; Vaccination coverage

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CONFERENCE PAPER; DIARRHEA; EPIDEMIC; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL SYMPTOM; GENOTYPE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VIRUS; PNEUMONIA; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SPAIN; THROAT CULTURE; URINE CULTURE; VOMITING; AGE; CLASSIFICATION; EPIDEMIOLOGY; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 84874747950     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.23265     Document Type: Conference Paper

References (31)

1. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004; 189(Suppl 1):S4-16; PMID:15106083; http://dx.doi.org/10.1086/ 377712.
2. Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005; 192:1686-93; PMID:16235165; http://dx.doi.org/10.1086/497169.
3. World Health Organization. Proceedings of the Global Technical Consultation to assess the feasibility of measles eradication, 28-30 July 2010. J Infect Dis 2011; 204(Suppl 1):S4-13; PMID:21666191; http://dx.doi.org/10.1093/ infdis/jir100.
4. Moss WJ, Strebel P. Biological feasibility of measles eradication. J Infect Dis 2011; 204(Suppl 1):S47-53; PMID:21666201; http://dx.doi.org/10.1093/ infdis/jir065.
5. Filia A, Tavilla A, Bella A, Magurano F, Ansaldi F, Chironna M, et al. Measles in Italy, July 2009 to September 2010. Euro Surveill 2011; 16:16; PMID:21801692.
6. Muscat M, Bang H, Wohlfahrt J, Glismann S, Mølbak K; EUVAC.NET Group. Measles in Europe: an epidemiological assessment. Lancet 2009; 373:383-9; PMID:19131097; http://dx.doi.org/10.1016/S0140-6736(08)61849-8.
7. Delaporte E, Richard JL, Wyler Lazarevic CA, Lacour O, Girard M, Ginet C, et al. Ongoing measles outbreak, Geneva, Switzerland, January to March 2011. Euro Surveill 2011; 16:16; PMID:21435325.
8. Mankertz A, Mihneva Z, Gold H, Baumgarte S, Baillot A, Helble R, et al. Spread of measles virus D4-Hamburg, Europe, 2008-2011. Emerg Infect Dis 2011; 17:1396-401; PMID:21801615.
9. Benkimoun P. Outbreak of measles in France shows no signs of abating. BMJ 2011; 342:d3161; PMID:21602242; http://dx.doi.org/10.1136/bmj.d3161.
10. Salleras L, Dominguez A, Torner N. Confirmed interruption of indigenous measles transmission in Catalonia. Euro Surveill 2001; 6:113-7; PMID:12631955.
11. Domínguez A, Torner N, Barrabeig I, Rovira A, Rius C, Cayla J, et al.; Working Group for the Study of the Measles Outbreak in Catalonia. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule. Clin Infect Dis 2008; 47:1143-9; PMID:18823269; http://dx.doi.org/10.1086/592258.
12. Hegasy G, Kätzner K, Helle M, Mankertz A, Baumgarte S, Wille A, et al. Description of measles D4-Hamburg outbreak in Hamburg, Germany, December 2008 to June 2009, which disproportionally affected a local Roma community. Euro Surveill 2012; 17:17; PMID:22720769.
13. Stanescu A, Janta D, Lupulescu E, Necula G, Lazar M, Molnar G, et al. Ongoing measles outbreak in Romania, 2011. Euro Surveill 2011; 16:16; PMID:21871218.
14. Vivancos R, Keenan A, Farmer S, Atkinson J, Coffey E, Dardamissis E, et al. An ongoing large outbreak of measles in Merseyside, England, January to June 2012. Euro Surveill 2012; 17:17; PMID:22835470.
15. Komitova R, Kunchev A, Mihneva Z, Marinova L. Nosocomial transmission of measles among healthcare workers, Bulgaria, 2010. Euro Surveill 2011; 16:16; PMID:21507322.
16. Centers for Disease Control and Prevention (CDC). Progress in global measles control, 2000-2010. MMWR Morb Mortal Wkly Rep 2012; 61:73-8; PMID:22298303.
17. Castillo-Solorzano C, Marsigli C, Danovaro-Holliday MC, Ruiz-Matus C, Tambini G, Andrus JK. Measles and rubella elimination initiatives in the Americas: lessons learned and best practices. J Infect Dis 2011; 204(Suppl 1):S279-83; PMID:21666173; http://dx.doi.org/10.1093/infdis/jir216.
18. Bassetti M, Schenone E, Calzi A, Camera M, Valle L, Ansaldi F, et al. Measles outbreak in adults in Italy. Infez Med 2011; 19:16-9; PMID:21471742.
19. Ciofi Degli Atti ML, Filia A, Massari M, Pizzuti R, Nicoletti L, D'Argenzio A, et al.; SPES Study Group. Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region. Vaccine 2006; 24:1332-8; PMID:16219394; http://dx.doi.org/10.1016/j.vaccine. 2005.09.031. (Pubitemid 43222041)
20. Barrabeig I, Rovira A, Muñoz P, Batalla J, Rius C, Sánchez JA, et al. MMR vaccine effectiveness in an outbreak that involved day-care and primary schools. Vaccine 2011; 29:8024-31; PMID:21893145; http://dx.doi.org/10. 1016/j.vaccine.2011.08.056.
21. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis 2011; 204(Suppl 1):S514-23; PMID:21666208; http://dx.doi.org/10.1093/ infdis/jir118.
22. Cilla G, Montes M, Artieda J, Pineiro L, Arriola L, Perez-Trallero E. Measles genotypes D4 and G3 reintroduced by multiple foci after 15 years without measles virus circulation, Gipuzkoa, the Basque Country, Spain, March to June 2011. Euro Surveill 2011; 16:16; PMID:22085599.
23. Melidou A, Gioula G, Pogka V, Exindari M, Moutoussi A, Sgouras D, et al. Molecular and phylogenetic analysis of Greek measles 2010 strains. Epidemiol Infect 2012; 140:432-8; PMID:21676352; http://dx.doi.org/10.1017/ S095026881100094X.
24. Borràs E, Domínguez A, Batalla J, Torner N, Cardeñosa N, Nebot M, et al. Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine 2007; 25:3240-3; PMID:17320249; http://dx.doi.org/10.1016/j.vaccine. 2007.01.026. (Pubitemid 46505046)
25. Botelho-Nevers E, Cassir N, Minodier P, Laporte R, Gautret P, Badiaga S, et al. Measles among healthcare workers: a potential for nosocomial outbreaks. Euro Surveill 2011; 16:16; PMID:21251488.
26. Paulussen TG, Hoekstra F, Lanting CI, Buijs GB, Hirasing RA. Determinants of Dutch parents' decisions to vaccinate their child. Vaccine 2006; 24:644-51; PMID:16157423; http://dx.doi.org/10.1016/j.vaccine.2005.08.053. (Pubitemid 43017831)
27. Jacobson RM, Targonski PV, Poland GA. A taxonomy of reasoning flaws in the anti-vaccine movement. Vaccine 2007; 25:3146-52; PMID:17292515; http://dx.doi.org/10.1016/j.vaccine.2007.01.046. (Pubitemid 46482757)
28. May T, Silverman RD. 'Clustering of exemptions' as a collective action threat to herd immunity. Vaccine 2003; 21:1048-51; PMID:12559778; http://dx.doi.org/10.1016/S0264-410X(02)00627-8. (Pubitemid 36139933)
29. Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis 2011; 204(Suppl 1):S559-63; PMID:21666213; http://dx.doi.org/10.1093/infdis/jir098.
30. Viana PO, Ono E, Miyamoto M, Salomao R, Costa-Carvalho BT, Weckx LY, et al. Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen. J Clin Immunol 2010; 30:574-82; PMID:20405177; http://dx.doi.org/10.1007/s10875-010- 9420-7.
31. Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, et al. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals. J Infect Dis 2011; 204(Suppl 1):S549-58; PMID:21666212; http://dx.doi.org/10.1093/infdis/jir106.